Cancer Medicine, Radiology & Treatment

Welcome Message

Dear Colleagues, Researchers, and Esteemed Experts,

It is our great pleasure and honor to welcome you to the 6th Experts Meeting on Cancer Medicine, Radiology & Treatment, scheduled for September 29–30, 2027, in Paris, France.

This international meeting serves as a valuable platform for bringing together leading oncologists, cancer researchers, radiologists, healthcare professionals, and scientific experts from across the globe to exchange knowledge, share groundbreaking discoveries, and explore innovative approaches to cancer prevention, diagnosis, and treatment.

Guided by the theme “Innovating Cancer Care for a Healthier Future,” this meeting will highlight the latest advancements in cancer medicine, diagnostic imaging, radiological technologies, precision oncology, and emerging therapeutic strategies. It aims to encourage meaningful scientific discussions, strengthen international collaborations, and promote advancements that can make a lasting difference in cancer care.

We are delighted to welcome you to this global gathering and look forward to your valuable contributions, inspiring discussions, and knowledge-sharing experiences. Together, let us explore new possibilities, advance scientific excellence, and contribute towards a healthier future for patients worldwide.

We look forward to welcoming you to the beautiful city of Paris for an inspiring and successful meeting!

Warm regards,
Organizing Committee
6th Experts Meeting on Cancer Medicine, Radiology & Treatment 2027

Sessions& Tracks

Cancer Cell Biology & Genetics

Cancer cell biology focuses on understanding the molecular structure, function, and behavior of cancer cells. Genetic mutations and DNA damage play a significant role in the development and progression of malignancies. Abnormal cell signaling and uncontrolled cell division contribute to tumor formation. Genomic instability further promotes cancer progression and resistance to treatment. Understanding these mechanisms supports the development of innovative diagnostic and therapeutic approaches.

Advances in Cancer Diagnosis & Early Detection

Early cancer diagnosis is essential for improving survival rates and treatment outcomes. Modern diagnostic approaches include molecular biomarkers, liquid biopsies, advanced imaging, and genetic testing. Artificial intelligence is increasingly supporting accurate interpretation of diagnostic results. Innovative screening technologies enable the identification of malignancies at earlier stages. These advancements contribute to timely intervention and more effective cancer management.

 Precision Oncology & Personalized Medicine

Precision oncology focuses on developing individualized treatment strategies based on the genetic and molecular characteristics of each patient's cancer. Genomic profiling helps identify specific mutations and potential therapeutic targets. Targeted therapies are designed to interfere with molecular pathways responsible for cancer growth. Personalized treatment approaches can improve therapeutic effectiveness and reduce unnecessary adverse effects. Advances in precision medicine are transforming modern oncology practice.

Radiation Oncology & Advanced Radiotherapy

Radiation oncology uses high-energy radiation to destroy cancer cells and control tumor growth. Advanced techniques such as intensity-modulated radiation therapy, image-guided radiotherapy, and stereotactic radiosurgery improve treatment accuracy. Proton therapy offers additional opportunities for precisely targeting tumors while limiting radiation exposure to surrounding healthy tissues. Modern treatment planning integrates advanced imaging and computational technologies. These innovations contribute to safer and more effective cancer treatment.

Immunotherapy & Targeted Cancer Treatment

Cancer immunotherapy utilizes the body's immune system to recognize and eliminate malignant cells. Immune checkpoint inhibitors, CAR-T cell therapy, monoclonal antibodies, and cancer vaccines represent important therapeutic developments. Targeted treatments focus on specific molecular pathways involved in cancer progression. Combination therapies are being investigated to overcome treatment resistance and improve clinical outcomes. These approaches are expanding treatment possibilities across different cancer types.

Cancer Imaging & Diagnostic Radiology

Diagnostic radiology plays a fundamental role in cancer detection, staging, treatment planning, and disease monitoring. Advanced imaging technologies include magnetic resonance imaging, computed tomography, PET-CT, and molecular imaging. Artificial intelligence and machine learning are improving image interpretation and diagnostic precision. Radiomics enables the extraction of quantitative information from medical images to support personalized treatment decisions. Continuous technological advancements are strengthening the role of imaging in modern cancer care.

Surgical Oncology & Minimally Invasive Techniques

Surgical oncology focuses on the diagnosis, removal, and management of cancerous tumors through specialized surgical procedures. Minimally invasive techniques, including laparoscopy and robotic-assisted surgery, are transforming surgical cancer treatment. Image-guided interventions improve precision in tumor localization and removal. Advances in surgical technologies help reduce complications and support faster postoperative recovery. Multidisciplinary collaboration ensures effective surgical planning and comprehensive patient care.

Hematologic Malignancies & Blood Cancer Research

Hematologic malignancies include leukemia, lymphoma, and multiple myeloma, which affect blood cells, bone marrow, and the lymphatic system. Advances in molecular diagnostics are improving the classification and detection of blood cancers. Stem cell transplantation, CAR-T cell therapy, and targeted medications are creating new treatment opportunities. Researchers are exploring innovative approaches to overcome drug resistance and disease relapse. These developments are contributing to more personalized and effective hematologic cancer management.

Cancer Prevention, Epidemiology & Risk Factors

Cancer prevention involves identifying and reducing lifestyle, environmental, genetic, and occupational risk factors associated with malignancies. Epidemiological research helps identify cancer patterns, population-based risks, and emerging trends. Vaccination programs, including HPV and hepatitis B vaccination, play an important role in preventing certain cancers. Lifestyle modifications, regular screening, and public health awareness support early intervention. Integrated prevention strategies are essential for reducing the global burden of cancer.

 Palliative Care & Supportive Oncology

Palliative care focuses on improving the quality of life of patients living with cancer at different stages of their disease. Effective pain management and symptom control are essential components of comprehensive cancer care. Psychological counseling, nutritional support, rehabilitation, and emotional assistance address patients' broader needs. Supportive oncology also helps manage treatment-related complications and improve patient well-being. A multidisciplinary approach ensures compassionate, coordinated, and patient-centered cancer care.

Artificial Intelligence & Machine Learning in Cancer Research

Artificial intelligence is transforming cancer research through advanced computational analysis and predictive modeling. Machine learning algorithms are being developed to identify cancer patterns in medical images, pathology slides, and genomic datasets. AI-based tools support early detection, tumor classification, and prediction of treatment responses. Deep learning applications are also accelerating drug discovery and clinical decision-making. Current research focuses on integrating AI into precision oncology while improving accuracy, transparency, and clinical reliability.

Liquid Biopsy & Circulating Tumor DNA Research

Liquid biopsy is an emerging diagnostic approach that detects cancer-related biomarkers through blood and other body fluids. Circulating tumor DNA (ctDNA) provides valuable information about tumor mutations, disease progression, and treatment response. Recent research explores its application in minimal residual disease detection and early identification of cancer recurrence. Advanced sequencing and fragmentomics are improving the sensitivity of molecular analysis. These developments may support personalized cancer monitoring and more informed treatment decisions.

Personalized mRNA Cancer Vaccines & Neoantigen Research

Personalized cancer vaccines are being investigated to stimulate immune responses against tumor-specific mutations. Messenger RNA technology enables the development of vaccines targeting individual cancer-associated neoantigens. Recent clinical research has demonstrated promising immune responses and encouraging recurrence-related outcomes in selected patient groups. Scientists are exploring combinations with immune checkpoint inhibitors to enhance therapeutic effectiveness. Further studies are evaluating vaccine safety, durability, and potential applications across different cancer types.

Radiopharmaceuticals & Molecular Radiotheranostics

Radiopharmaceutical research combines molecular imaging and targeted radiation therapy to improve cancer diagnosis and treatment. These approaches use radioactive compounds designed to identify or selectively destroy malignant cells. Emerging research focuses on alpha-emitting radionuclides, beta emitters, and novel tumor-targeting molecules. Advanced PET imaging supports patient selection, treatment planning, and response monitoring. Personalized dosimetry and improved radioligand delivery are important areas of ongoing investigation.

Tumor Microenvironment & Cancer Immune Resistance

The tumor microenvironment consists of cancer cells, immune cells, blood vessels, and surrounding supporting tissues. Recent research investigates how interactions between these components influence tumor growth and therapeutic resistance. Scientists are studying cancer-associated fibroblasts, immune-suppressive cells, and inflammatory signaling pathways. Understanding these mechanisms may help improve responses to immunotherapy and targeted treatments. Novel strategies aim to modify the tumor microenvironment to make cancer cells more vulnerable to treatment.

Single-Cell Genomics & Spatial Transcriptomics in Oncology

Single-cell genomics enables researchers to investigate genetic variations and molecular characteristics at the individual cell level. Spatial transcriptomics examines gene expression while preserving the physical organization of cells within tumor tissues. These technologies provide deeper insights into tumor heterogeneity and cellular interactions. Recent research integrates genomic, transcriptomic, and proteomic information to understand cancer progression. Such approaches may identify new therapeutic targets and improve personalized treatment strategies.

Cancer Organoids & 3D Tumor Modeling

Cancer organoids are three-dimensional laboratory models developed from patient-derived tumor cells or tissues. They reproduce important structural and molecular characteristics of human tumors. Researchers are using organoid models to investigate cancer development, drug resistance, and treatment responses. Integration with 3D bioprinting and advanced laboratory technologies offers new opportunities for experimental oncology. These models may support personalized drug screening and the development of more effective therapeutic approaches.

KRAS Mutations & Next-Generation Targeted Therapies

KRAS mutations are important molecular drivers associated with several aggressive cancer types, including pancreatic, colorectal, and lung cancers. Recent research focuses on developing next-generation inhibitors targeting different KRAS mutations. Scientists are also investigating KRAS protein degraders and innovative combination therapies. Immunotherapy and molecular approaches are being explored to overcome resistance to existing targeted treatments. These developments offer promising directions for treating cancers driven by difficult-to-target genetic alterations.

Antibody-Drug Conjugates & Next-Generation Cancer Therapeutics

Antibody-drug conjugates (ADCs) are innovative therapies that combine cancer-targeting antibodies with highly potent cytotoxic drugs. These treatments are designed to deliver therapeutic agents more selectively to malignant cells. Current research focuses on improving antibody specificity, linker stability, drug payloads, and treatment effectiveness. Novel ADC combinations with immunotherapy and other targeted agents are being investigated. Advances in this field may expand treatment opportunities across multiple solid tumors and hematologic malignancies.

Advanced Cancer Imaging & AI-Driven Radiogenomics

Advanced cancer imaging integrates radiological technologies with computational analysis to improve tumor characterization and clinical assessment. Radiogenomics investigates relationships between imaging features and underlying molecular or genetic alterations. Emerging technologies include photon-counting CT, ultra-high-field MRI, and AI-assisted image analysis. Researchers are exploring imaging biomarkers to predict tumor behavior and treatment responses. These innovations support more accurate diagnosis, individualized treatment planning, and precision cancer management.

 Emerging Trends in Cancer Medicine

Emerging trends in cancer medicine focus on innovative scientific discoveries and advanced approaches to cancer prevention, diagnosis, and treatment. Recent research explores molecular therapies, immunotherapy, precision medicine, and novel drug development. Advances in genomic profiling and biomarker identification are improving understanding of cancer progression. Innovative clinical approaches are being investigated to overcome treatment resistance and improve patient outcomes. These developments are shaping the future of personalized and evidence-based cancer care.

 Novel Therapeutic Strategies & Clinical Innovations

Novel therapeutic strategies aim to improve cancer treatment through innovative drugs, advanced technologies, and combination therapies. Current research investigates antibody-drug conjugates, next-generation immunotherapies, targeted molecular inhibitors, and personalized cancer vaccines. Clinical trials play an essential role in evaluating the safety and effectiveness of emerging treatments. Researchers are exploring new approaches to overcome drug resistance and prevent disease recurrence. These innovations offer promising opportunities to improve therapeutic outcomes across different cancer types.

 Advanced Cancer Imaging & Radiological Technologies

Advanced cancer imaging focuses on developing innovative radiological techniques for accurate tumor detection, characterization, and treatment monitoring. Recent advancements include photon-counting CT, advanced MRI, PET imaging, and molecular radiology. Artificial intelligence and deep learning are improving image interpretation and supporting early diagnosis. Radiomics and quantitative imaging biomarkers provide valuable insights into tumor biology and treatment response. These technologies are advancing precision radiology and improving clinical decision-making in oncology.

Molecular Oncology & Translational Research

Molecular oncology investigates the genetic, epigenetic, and cellular mechanisms responsible for cancer development and progression. Current research explores gene mutations, tumor heterogeneity, molecular signaling pathways, and interactions within the tumor microenvironment. Translational research connects laboratory discoveries with clinical applications and innovative treatment development. Advanced genomic sequencing and molecular profiling are helping identify new therapeutic targets. These investigations contribute to developing more effective and individualized cancer treatment strategies.

Next-Generation Cancer Diagnostics & Precision Medicine

Next-generation cancer diagnostics integrates advanced molecular technologies, genomic sequencing, liquid biopsies, and artificial intelligence. Researchers are investigating circulating tumor DNA, minimal residual disease, and novel biomarkers for earlier cancer detection. Precision medicine uses individual tumor characteristics to guide treatment selection and improve therapeutic outcomes. Advanced diagnostic platforms are also supporting real-time monitoring of disease progression and treatment response. These innovations are creating new possibilities for personalized, accurate, and timely cancer management.